Time to Treatment and Risk Factors for Unsuccessful Treatment Outcomes among People Who Started Second-Line Treatment for Rifampicin-Resistant or Multi-Drug-Resistant Tuberculosis in the Kyrgyz Republic, 2021

The Kyrgyz Republic is a high-burden country for rifampicin resistant/multi-drug resistant tuberculosis (RR/MDR-TB). TB control efforts rely on early diagnosis and initiation of people on effective regimens. We studied the interval from diagnosis of RR-TB to starting treatment and risk factors for u...

Descripción completa

Detalles Bibliográficos
Autores principales: Kyrbashov, Bolot, Kulzhabaeva, Aizat, Kadyrov, Abdullaat, Toktogonova, Atyrkul, Timire, Collins, Satyanarayana, Srinath, Istamov, Kylychbek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459505/
https://www.ncbi.nlm.nih.gov/pubmed/37624346
http://dx.doi.org/10.3390/tropicalmed8080407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459505/
https://www.ncbi.nlm.nih.gov/pubmed/37624346
http://dx.doi.org/10.3390/tropicalmed8080407

Ejemplares similares